4//SEC Filing
Campbell Robert 4
Accession 0001127602-09-014345
CIK 0001145197other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:51 PM ET
Size
14.1 KB
Accession
0001127602-09-014345
Insider Transaction Report
Form 4
INSULET CORPPODD
Campbell Robert
Vice President for Clinical
Transactions
- Exercise/Conversion
Common Stock
2009-06-19$2.84/sh+179$508→ 60,273 total - Exercise/Conversion
Common Stock
2009-06-19$5.94/sh+356$2,115→ 61,224 total - Exercise/Conversion
Stock Option (Right to Buy)
2009-06-19−179→ 0 totalExercise: $2.84Exp: 2014-11-01→ Common Stock (179 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2009-06-19−356→ 359 totalExercise: $5.94Exp: 2016-03-13→ Common Stock (356 underlying) - Exercise/Conversion
Common Stock
2009-06-19$3.60/sh+595$2,142→ 60,868 total - Exercise/Conversion
Stock Option (Right to Buy)
2009-06-19−595→ 0 totalExercise: $3.60Exp: 2015-04-11→ Common Stock (595 underlying)
Footnotes (1)
- [F1]This option may be exercised at any time, whether vested or not, but, upon termination of employment, we may repurchase any unvested shares at the exercise price paid for the shares. This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal monthly installments each month thereafter for 36 months, subject to continued employment.
Documents
Issuer
INSULET CORP
CIK 0001145197
Entity typeother
Related Parties
1- filerCIK 0001404060
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:51 PM ET
- Size
- 14.1 KB